Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review BioDrugs (2017) 31:299–316 DOI 10.1007/s40259-017-0231-8 SYSTEMATIC REVIEW Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review 1 2 3 4 • • • • Vibeke Strand Alejandro Balsa Jamal Al-Saleh Leonor Barile-Fabris 5 6 7 8 • • • • Takahiko Horiuchi Tsutomu Takeuchi Sadiq Lula Charles Hawes 8 9 Blerina Kola Lisa Marshall Published online: 13 June 2017 The Author(s) 2017. This article is an open access publication Abstract (AS), non-radiographic axial spondyloarthritis (nr-axSpA), Objectives A systematic review was conducted to explore psoriasis (Ps), Crohn’s disease, and ulcerative colitis. the immunogenicity of biologic agents across inflammatory Results Of [21,000 screened publications, 443 were diseases and its potential impact on efficacy/safety. included. Anti-drug antibody (ADAb) rates varied widely Methods Literature searches were conducted through among biologics across diseases (and are not directly November 2016 to identify controlled and observational comparable because of immunoassay heterogeneity); the studies of biologics/biosimilars administered for treatment highest overall rates were reported with infliximab of rheumatoid arthritis (RA), psoriatic arthritis (PsA), (0–83%), adalimumab (0–54%), and infliximab biosimilar juvenile idiopathic arthritis (JIA), ankylosing spondylitis CT-P13 (21–52%), and the lowest with secukinumab (0–1%), ustekinumab (1–11%), etanercept (0–13%), and golimumab (0–19%). Most ADAbs were neutralizing, Electronic supplementary http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BioDrugs Springer Journals

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

Loading next page...
 
/lp/springer_journal/immunogenicity-of-biologics-in-chronic-inflammatory-diseases-a-tdoo0icJUx
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Biomedicine; Molecular Medicine; Antibodies; Cancer Research; Pharmacotherapy
ISSN
1173-8804
eISSN
1179-190X
D.O.I.
10.1007/s40259-017-0231-8
Publisher site
See Article on Publisher Site

Abstract

BioDrugs (2017) 31:299–316 DOI 10.1007/s40259-017-0231-8 SYSTEMATIC REVIEW Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review 1 2 3 4 • • • • Vibeke Strand Alejandro Balsa Jamal Al-Saleh Leonor Barile-Fabris 5 6 7 8 • • • • Takahiko Horiuchi Tsutomu Takeuchi Sadiq Lula Charles Hawes 8 9 Blerina Kola Lisa Marshall Published online: 13 June 2017 The Author(s) 2017. This article is an open access publication Abstract (AS), non-radiographic axial spondyloarthritis (nr-axSpA), Objectives A systematic review was conducted to explore psoriasis (Ps), Crohn’s disease, and ulcerative colitis. the immunogenicity of biologic agents across inflammatory Results Of [21,000 screened publications, 443 were diseases and its potential impact on efficacy/safety. included. Anti-drug antibody (ADAb) rates varied widely Methods Literature searches were conducted through among biologics across diseases (and are not directly November 2016 to identify controlled and observational comparable because of immunoassay heterogeneity); the studies of biologics/biosimilars administered for treatment highest overall rates were reported with infliximab of rheumatoid arthritis (RA), psoriatic arthritis (PsA), (0–83%), adalimumab (0–54%), and infliximab biosimilar juvenile idiopathic arthritis (JIA), ankylosing spondylitis CT-P13 (21–52%), and the lowest with secukinumab (0–1%), ustekinumab (1–11%), etanercept (0–13%), and golimumab (0–19%). Most ADAbs were neutralizing, Electronic supplementary

Journal

BioDrugsSpringer Journals

Published: Jun 13, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off